Tag: Cardea Solo

Cardiac Insight’s Cardea SOLO™ Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women

BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, today announced that researchers at Stanford Medicine selected the company’s Cardea SOLO™ wearable ECG system for a […]

Cardiac Insight Announces Partnership with Lovell Government Services to Extend Distribution Capabilities to U.S. Department of Defense and Veterans Affairs Medical Facilities

Partnership Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis to Veterans and Active-Duty Military Personnel BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc.(“Cardiac Insight” or the “Company”) is a US-based healthcare innovator specializing in wearable cardiac […]

Cardiac Insight Awarded Wearable Medical Devices and Mobile Medical Applications Category Group Purchasing Agreement with Premier

Agreement Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically […]

Cardiac Insight Launches New Telehealth Solution for Cardiology Practices with Heart@Home™ ECG Test Kit

Direct-to-patient Cardea SOLO™ wearable ECG speeds clinical decision-making while removing costly and time-consuming outsourcing of data analysis Bellevue, WA, April 16, 2020 (GLOBE NEWSWIRE) — Cardiac Insight, Inc., a US-based digital healthcare innovator specializing in body-worn sensor technology and automated electrocardiogram […]

Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.) to Expand the Use of Its Wearable Cardiac Sensors in Regulated Pharmaceutical Clinical Trials and Other Healthcare Research Applications

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac biosensors and clinical diagnostic software systems featuring proprietary automated data analysis algorithms, announced today it has partnered with VivoSense®, a leader in integration and specialized analysis of wearable sensor […]

Cardiac Insight Announces FDA Clearance of “CARDEA SOLO™” – The First Wearable (ECG) Sensor Giving Physicians Immediate Access to Complete Cardiac Arrhythmia Data and Analysis

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced today, the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO™. The device offers physicians immediate access to improved reporting and analysis […]